Xenogenic Bone Intentionally Left Exposed
Effect of Healing Xenogenic Biomaterial Exposed to the Oral Environment in Humans
1 other identifier
observational
28
1 country
1
Brief Summary
The goal of this clinical trial is to compare, the effect of letting the xenogeneic bone graft exposed to the oral environment or seal off the graft with a collagen matrix. Them main questions it aims to answer are:
- The enhancement of soft tissue healing during the initial phases following immediate implant placement.
- The secondary aim is to evaluate the dimensional alterations in hard tissues at immediately placed implants and different biomaterial protocol. It were selected patients with indication of flapless extraction in posterior teeth, which was placed immediate implant (n=28) and gap filling with deproteinized bovine bone mineral (Geistlich Bio-Oss®). In this study, participants were stratified into two randomized blocks, each corresponding to a distinct surgical technique: left exposed the graft to the oral environment or coverage with a collagen matrix (Geistlich Mucograft®).
- Previously the extraction was performed the measurement of the keratinized gingiva, and after 04 months of implant placement.
- The soft tissue healing was evaluated on days 02, 07, 30 days; by means of a blue-stained solution (methylene blue 0.05%) and standardized photograph.
- In the same date from different healing times it was performed immunoenzymatic analysis of the levels of VEGF (vascular endothelial growth factor), IL-1β (interleukin-1β) and FGF2 (fibroblast growth factor 2).
- It was also be performed cone beam computed tomography images quantifying the soft and hard tissues thickness of the facial and lingual bone wall. The clinical trial examiner was blinded during the study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2022
CompletedFirst Submitted
Initial submission to the registry
December 20, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedAugust 5, 2024
August 1, 2024
2.3 years
December 20, 2023
August 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Keratinized Mucosa Width
The keratinized mucosa width was evaluated using a periodontal probe at the facial level before extraction and after 4 months at the implant placement.
before extraction, after 1-2 months post implant placement, and after the emergence contour of a prosthesis (up to 4 months).
Secondary Outcomes (1)
Cone Beam Computed Tomographs Measurements
Baseline; after 4 months
Other Outcomes (2)
Clinical Assessment of Epithelialization
2 day, 1 week, and 1 month after the implant placement
Serum levels of cytokines
2 day, 1 week, and 1 month after the implant placement
Study Arms (2)
Experimental Group
The aim of this study is to assess the effectiveness of usage of xenogeneic bone intentionally left exposed to the oral environment after immediate implant placement in preserving keratinized mucosa and the alveolar ridge height and width preservation, without compromising the healing process.
Control group
The aim of this study is to evaluate whether the use of collagen matrix has benefits when compared to xenogeneic bone intentionally left exposed to the oral environment after immediate implant placement.
Interventions
Molar extraction with a flapless approach and immediate implant installation, filling the gap with deproteinized bovine bone mineral (Geistlich Bio-Oss) and left exposed to the oral environment.
Molar extraction with a flapless approach and immediate implant installation, filling the gap with deproteinized bovine bone mineral (Bio-Oss; Geistlich) and covered by a collagen matrix (Mucograft; Geistlich).
Eligibility Criteria
Patients with hopeless molar teeth who are scheduled for immediate implant placement in this area, in the researcher's town.
You may qualify if:
- Healthy adults (≥18 years-old) exhibiting good oral hygiene,
- Hopeless molar teeth with an intact buccal socket wall,
- Sufficient apical bone allowing for immediate implant placement.
You may not qualify if:
- Individuals with systemic diseases that are unstable,
- Uncontrolled metabolic conditions,
- Daily smoking habit of ≥10 cigarettes,
- Those who have received antibiotic drugs or corticosteroids within the past 3 months, or are currently on medications that impact bone healing, such as bisphosphonates,
- Patients with a past history of chemotherapy or radiation therapy in the oral and maxillofacial region.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sao Paulolead
- São Paulo State Universitycollaborator
- Universidade Federal de Sergipecollaborator
Study Sites (1)
School of Dentistry of Ribeirão Preto - University of Sao Paulo
Ribeirão Preto, São Paulo, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valessa F Carvalho, PhD student
School of Dentistry of Ribeirão Preto
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Phd, Ms, DDs. Chairman of Periodontolgy
Study Record Dates
First Submitted
December 20, 2023
First Posted
January 5, 2024
Study Start
December 17, 2019
Primary Completion
April 14, 2022
Study Completion
June 15, 2022
Last Updated
August 5, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share